Yüklüyor......
Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial
BACKGROUND AND OBJECTIVES: Vaccination with Human Papillomavirus (HPV) vaccine is recommended for 11–12 years-old, but uptake is suboptimal. Current messaging focuses on HPV infection transmission and prevention. Parents and providers are often uncomfortable discussing sexual practices of adolescent...
Kaydedildi:
| Yayımlandı: | Vaccine |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550298/ https://ncbi.nlm.nih.gov/pubmed/29599089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.01.040 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|